IJPR  articles are Indexed in SCOPUSClick Here     Impact Factor for Five Years is 1.55 (2012 - 2016).    Offical Sponser for International Conference in malaysia ,  https://www.icmhas.com/

logo

INTERNATIONAL JOURNAL OF PHARMACEUTICAL RESEARCH

A Step Towards Excellence

IJPR included in UGC-Approved List of Journals - Ref. No. is SL. No. 4812 & J. No. 63703

ISSN
0975-2366
5 - Years Impact Factor

Year 2012 - 2016

Impact Factor: 1.55

Total Publications: 317

Total Citation: 491

Year 2011 - 2015

Impact Factor: 1.46

Total Publications: 326

Total Citation: 477

Year 2010 - 2014

Impact Factor: 1.3

Total Publications: 313

Total Citation: 407

Year 2009 - 2013

Impact Factor: 0.973

Total Publications: 293

Total Citation: 285

Current Issue
22nd NATIONAL CONVENTION

22nd National Convention of Society of Pharmacognosy & International Conference. For more details visit


For More Detail Visit ncsp.ganpatuniversity.ac.in
Article In Press
ADOBE READER

(Require Adobe Acrobat Reader to open, If you don't have Adobe Acrobat Reader)

Index Page 1
Click here to Download
IJPRT ISSUE

January - March 6 [1] 2014

Click to download
IJPR 9[3] July - September 2017 Special Issue

July - September 9[3] 2017

Click to download
PIPPHARMACON & IJPR 2018

PIPPHARMACON & IJPR 2018

Click to download
 

Article Detail

Label
Label
Cost-benefit Analysis of Clinical Preventive Services: Perspective of Pharmacists in Tertiary Hospitals in South-Eastern Nigeria

Author: ANOSIKE, CHIBUEZE*, ADIBE. MAXWELL OGOCHUKWU, IGBOELI, NNEKA UCHENNA
Abstract: Aim: This study aimed to conduct a cost-benefit analysis of hospital pharmacists provided clinical preventive services in tertiary hospitals in South-Eastern Nigeria. Methods: A cross-sectional study was conducted among out-patients in two tertiary hospitals. Using contingent valuation, we elicited respondents’ willingness to pay (WTP) for pharmacists provided clinical preventive services (CPS). The cost of providing CPS was calculated from the perspective of pharmacists. Benefit-cost ratio (BCR) and price elasticity of demand for CPS were calculated. Descriptive statistics was used to present patients’ sociodemographic characteristics. The predictors of WTP and WTP amount for CPS was modelled using multivariate regression. P values < 0.05 were considered statistically significant. Results: Of the 466 participants, about 71% of the respondents were willing to pay an average of US$0.85 ± 1.16 for CPS. BCR for CPS was 2.38 (95% CI 2.25-6.99). Price elasticity of demand for CPS was inelastic. Patients with self-reported “average health status” had 66.7% higher WTP odds for CPS than those with “good health status.” Every unit increase in monthly income led to US$0.27 increase in WTP amount for CPS. Conclusion: Our findings showed high patient acceptance of CPS, as a substantial proportion were willing to pay for the service. Pharmacists provided CPS was cost-beneficial as every dollar spent returns about US$2.4 for the service providers. However, income level and health status were major contributors of patients’ WTP for the service.
Keyword: Clinical preventive service, hospital pharmacists, cost-benefit analysis, contingent valuations
Download: Request For Article
 












USER LOGIN


Username
Password
Login | Register
AICTE INTERNATIONAL CONFERENCE

AICTE Sponsored International Conference on Challenges, Opportunities and Newer Directions of Pharmacovigilance and Clinical Research in India

Download Brochure


For More Detail Visit www.pippharmacon.org
News & Events
SCImago Journal & Country Rank
hit counters free
0.07
2017CiteScore
 
11th percentile
Powered by  Scopus
Impact Factor for five years is 1.55 (2012 - 2016)

Year 2011 - 2015 Impact Factor - 1.46 Total Publications - 326 Total Citations - 477